摘要 |
FIELD: medicine. SUBSTANCE: method involves administering a combination of progestin and nitrogen oxide synthase substratum, nitrogen oxide donor or both. The combination is optionally administered with one or several cyclo-oxigenase inhibitors, PGIPGI2-mimetic, thromboxan inhibitor (TXATXA2), a substance possessing TXATXA2-agonist properties, TXATXA2-inhibitor properties, a substance possessing TXATXA2- antagonist properties and PGIPGI2-mimetic activity, and TXATXA2- antagonist substance. EFFECT: enhanced effectiveness of treatment. 22 cl, 6 dwg, 2 tbl |